Ignite Creation Date:
2025-12-24 @ 3:54 PM
Ignite Modification Date:
2025-12-26 @ 9:59 AM
Study NCT ID:
NCT03400592
Status:
UNKNOWN
Last Update Posted:
2018-01-17
First Post:
2015-10-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Nimotuzumab and Irinotecan as Second Line With Recurrent or Metastatic Gastric Adenocarcinoma
Sponsor:
Peking University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-06
Start Date Type:
None
Primary Completion Date:
2018-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2018-06
Completion Date Type:
ESTIMATED
First Submit Date:
2015-10-10
First Submit QC Date:
None
Study First Post Date:
2018-01-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-09
Last Update Post Date:
2018-01-17
Last Update Post Date Type:
ACTUAL